Related Experiment Video
Updated: Jul 4, 2026
04:46
Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations
Published on: February 24, 2023
'Recurrent' glioblastoma multiforme, when should we reoperate?
Giuseppe M V Barbagallo1, Michael D Jenkinson, Andrew R Brodbelt
1Department of Neurosurgery, The Walton Centre for Neurology and Neurosurgery, Lower Lane, Fazakerly, Liverpool, UK. giuseppebarbagal@hotmail.com
British Journal of Neurosurgery
|June 24, 2008
Summary
Surgical re-operation for recurrent glioblastoma multiforme can extend survival by 3-5 months. Key factors for success include patient age and performance status, with benefits including symptom improvement and delayed progression.
Area of Science:
- Neuro-oncology
- Neurosurgery
- Cancer Research
Background:
- The optimal management of recurrent glioblastoma multiforme (GBM) remains a subject of debate.
- Emerging evidence suggests potential benefits of surgical intervention in select recurrent cases.
Purpose of the Study:
- To evaluate the efficacy and safety of re-operation for recurrent glioblastoma multiforme.
- To identify prognostic factors influencing outcomes after surgical management of recurrent GBM.
Main Methods:
- Review of recent publications and clinical data on surgical management of recurrent glioblastoma.
- Analysis of survival data, morbidity, mortality, and quality of life indicators.
Main Results:
- Re-operation in recurrent glioblastoma offers a median survival benefit of 3-5 months.
- Patient age (<=50 years) and Karnofsky performance score (>=60-70) are critical prognostic factors.
- Surgical intervention improves symptoms, quality of life, and can reduce corticosteroid dependence.
Conclusions:
- Surgical treatment for recurrent glioblastoma multiforme should be considered in carefully selected patients.
- Re-resection can improve quality of life and potentially enhance the efficacy of adjuvant therapies.
